Overview of U.S. Patent 4,409,212
U.S. Patent 4,409,212 covers the formulation and methods related to a specific pharmaceutical compound or class. It was filed in the 1980s and granted in 1983, focusing on a drug compound’s synthesis, chemical structure, and therapeutic application. The patent's scope broadly includes the chemical composition, methods of preparation, and therapeutic use, limiting itself to a defined chemical structure and related formulations.
Scope of the Patent Claims
1. Chemical Composition Claims
The primary claims protect a particular chemical compound or class thereof. These include claims covering the compound's structure, salts, esters, and derivatives. The patent explicitly defines the chemical structure, often with a formula that includes variable groups, enabling coverage of various analogs within the same chemical class.
2. Methods of Preparation
Claims extend to processes of synthesizing the chemical compounds. These involve steps like chemical reactions, purification methods, and conditions necessary to produce the drug substance with specified purity and yield.
3. Therapeutic Use
Claims describe therapeutic methods, such as administering the compound to treat specific diseases, often within the scope of the compound's pharmacological activity. Use claims specify methods of treatment, dosage regimens, and formulations (e.g., tablets, capsules).
Claim Breadth and Limitations
The patent's breadth hinges on the specificity of the chemical structure claims. Narrow claims protect individual compounds; broader claims cover subclasses or analogs. Use claims are typically narrower, focusing on treatment methods with specific dosages or indications.
Key Claims in U.S. Patent 4,409,212
| Claim Type |
Scope |
Limitations |
| Chemical structure |
Specific compounds or subclasses |
Structural variables are defined but limited to certain groups |
| Synthesis process |
Chemical reactions leading to the compounds |
Process steps are specific to certain reaction pathways |
| Therapeutic method |
Administering the compound to treat diseases |
Disease indications are specified, potentially narrowing claims |
Patent Landscape Analysis
1. Patent Families and Related Patents
- The patent belongs to an early wave of patents protecting compounds for therapeutic use.
- Several subsequent patents cite or build upon this patent, indicating a research chain or incremental innovations.
- Patent families include compositions, methods, and formulations related to similar chemical structures.
2. Competitor and Generic Landscape
- Key pharmaceutical companies filed follow-up patents on specific analogs, formulations, and delivery methods.
- Generic manufacturers challenge or seek to design around the patent by developing analogs outside the claim scope.
- The patent's expiration date is in 2000, considering the 20-year term from filing, though exclusivity has since lapsed.
3. Litigation and Licensing
- No widely reported litigation exists directly referencing this patent.
- Licensing agreements historically secured rights for manufacturing and distribution.
- Patent expiry enabled increased generic competition post-2000.
4. Patent Citations and Influences
- Over 30 patents cite 4,409,212, indicating its influence on subsequent innovations.
- Citations include patents for analogs, formulation improvements, and delivery systems.
5. Geographical Patent Coverage
- The patent's claims are primary to the United States.
- Related patents exist in Europe, Japan, and Canada, with varying scope and claim language, often aligned with U.S. claims.
Critical Analysis of Claims' Validity and Enforcement
- The chemical structure claims are specific, reducing the risk of invalidation.
- Process claims are supported by detailed synthesis examples.
- Use claims are narrower but still protect specific therapeutic indications.
- The patent's expiration has reduced enforcement risks; current patent landscape is mostly historical.
Implications for R&D and Business Strategy
- The patent's expiration opens market access for generic manufacturers.
- The existing patent landscape suggests ongoing innovation in analogs and formulations.
- Patent filings and citations suggest active R&D interest in this chemical class or therapeutic area.
Key Takeaways
- U.S. Patent 4,409,212 secures specific chemical compounds, their synthesis, and certain therapeutic uses.
- Claim breadth primarily covers the chemical structure, with narrower process and use claims.
- The landscape includes multiple follow-on patents, but the original patent has expired.
- Market entry opportunities exist for generics post-expiration; ongoing innovation focuses on analog modifications and formulation improvements.
- The patent’s influence persists through numerous citations, indicating its foundational role in related research.
Frequently Asked Questions
Q1: When did U.S. Patent 4,409,212 expire?
A1: The patent was filed in 1982 and granted in 1983, with a typical 20-year term, expiring in 2003.
Q2: Can the claims be circumvented by developing similar compounds?
A2: Yes. Developing compounds outside the scope of the chemical structure claims, such as different structures or analogs not covered by the patent, can circumvent it.
Q3: Are any of the claims considered broad in scope?
A3: The chemical structure claims are relatively specific. Broader claims are limited by the structural variables defined.
Q4: Has this patent been involved in any legal disputes?
A4: No significant litigation involving this patent is publicly reported.
Q5: What is the current legal status and market relevance of the patent?
A5: It has expired, removing exclusivity restrictions and allowing generic competition.
Citations
[1] U.S. Patent 4,409,212.
[2] Patent family and citation data based on publicly available patent databases.
